DK0974350T3 - Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette - Google Patents

Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette

Info

Publication number
DK0974350T3
DK0974350T3 DK97902588T DK97902588T DK0974350T3 DK 0974350 T3 DK0974350 T3 DK 0974350T3 DK 97902588 T DK97902588 T DK 97902588T DK 97902588 T DK97902588 T DK 97902588T DK 0974350 T3 DK0974350 T3 DK 0974350T3
Authority
DK
Denmark
Prior art keywords
tranilast
active ingredient
aqueous base
preparing
containing composition
Prior art date
Application number
DK97902588T
Other languages
English (en)
Inventor
Masao Mori
Noriyasu Saito
Original Assignee
Lead Chem Co Ltd
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Chem Co Ltd, Kissei Pharmaceutical filed Critical Lead Chem Co Ltd
Application granted granted Critical
Publication of DK0974350T3 publication Critical patent/DK0974350T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
DK97902588T 1996-02-07 1997-02-06 Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette DK0974350T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4549396 1996-02-07
PCT/JP1997/000283 WO1997028793A1 (fr) 1996-02-07 1997-02-06 Preparation a usage externe comprenant du tranilast et processus de production de cette preparation

Publications (1)

Publication Number Publication Date
DK0974350T3 true DK0974350T3 (da) 2002-11-25

Family

ID=12720933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902588T DK0974350T3 (da) 1996-02-07 1997-02-06 Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette

Country Status (12)

Country Link
US (1) US6239177B1 (da)
EP (1) EP0974350B1 (da)
JP (1) JP4154621B2 (da)
KR (1) KR100449939B1 (da)
CN (1) CN1081030C (da)
AT (1) ATE222759T1 (da)
DE (2) DE69715049T2 (da)
DK (1) DK0974350T3 (da)
ES (1) ES2151464T3 (da)
HK (1) HK1018218A1 (da)
PT (1) PT974350E (da)
WO (1) WO1997028793A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA199800721A1 (ru) * 1996-02-15 1999-02-25 Киссеи Фармасьютикал Ко., Лтд. Ингибитор реваскуляризации
JP4865958B2 (ja) * 2001-05-23 2012-02-01 株式会社トクホン 鎮痛抗炎症局所作用型の貼付剤
EP1559426B1 (en) * 2002-11-05 2011-02-09 Lead Chemical Co. Ltd. Percutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
JP2004307364A (ja) * 2003-04-03 2004-11-04 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
EP1685837A4 (en) * 2003-11-12 2009-03-25 Lead Chem Co Ltd BRAIN PROTECTIVE AGENT OF THE TYPE ADMINISTERED BY PERCUTANEOUS ABSORPTION
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
US9066912B2 (en) * 2003-11-17 2015-06-30 Ethicon, Inc. Drug-enhanced adhesion prevention
US20050239892A1 (en) * 2003-11-21 2005-10-27 Trustees Of Tufts College Therapeutic avenathramide compounds
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
JP4590224B2 (ja) * 2004-07-20 2010-12-01 株式会社日本点眼薬研究所 トラニラストまたは薬理学的に許容される塩を含有する懸濁性医薬組成物
WO2006018997A1 (ja) * 2004-08-18 2006-02-23 Medrx Co., Ltd. 外用剤
US7473738B2 (en) * 2004-09-30 2009-01-06 Johnson & Johnson Vision Care, Inc. Lactam polymer derivatives
US20080009519A1 (en) * 2004-11-17 2008-01-10 Lawrence Steinman Method of modulating t cell functioning
AU2005306585A1 (en) * 2004-11-17 2006-05-26 Nuon Therapeutics Pty Limited A method of modulating B cell functioning
JP2007051089A (ja) * 2005-08-18 2007-03-01 Medorekkusu:Kk 外用剤
JPWO2007046544A1 (ja) * 2005-10-21 2009-04-30 株式会社 メドレックス カルボキシル基を有する肥満細胞脱顆粒抑制剤と有機アミンとの塩を含有する外用剤
JP4959991B2 (ja) * 2006-03-03 2012-06-27 株式会社日本点眼薬研究所 トラニラストまたはその薬理学的に許容される塩を含有する懸濁性医薬組成物
NZ574028A (en) 2006-07-05 2010-10-29 Fibrotech Therapeutics Pty Ltd Tranilast analogues (substituted cinnamoyl anthranilate compounds) for treatment of conditions associated with firbrosis
US8883190B2 (en) * 2006-12-01 2014-11-11 Wake Forest University Health Sciences Urologic devices incorporating collagen inhibitors
EP2030617A1 (en) * 2007-08-17 2009-03-04 Sygnis Bioscience GmbH & Co. KG Use of tranilast and derivatives thereof for the therapy of neurological conditions
CN101152163B (zh) * 2007-09-14 2010-05-26 李世荣 含有激素类药物的抗瘢痕外用贴膜及其制备方法
CN101152164B (zh) * 2007-09-14 2011-04-06 李世荣 含有抗肥大细胞类药物的抗瘢痕外用贴膜及其制备方法
WO2011047432A1 (en) 2009-10-22 2011-04-28 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
ES2759582T3 (es) * 2011-06-20 2020-05-11 Hisamitsu Pharmaceutical Co Parche que contiene lidocaína
JP6096021B2 (ja) * 2013-03-22 2017-03-15 ファイテン株式会社 顎関節症用外用剤
JP6558117B2 (ja) * 2014-08-19 2019-08-14 大正製薬株式会社 皮膚用剤
MA41266A (fr) * 2014-12-22 2017-10-31 Hisamitsu Pharmaceutical Co Cataplasme
JP6434123B2 (ja) 2015-02-24 2018-12-05 久光製薬株式会社 パップ剤
CN104784101A (zh) * 2015-03-05 2015-07-22 中国药科大学制药有限公司 一种曲尼司特凝胶和软膏剂的处方及制备方法
KR101691472B1 (ko) 2015-07-06 2017-01-09 이광재 배낭에 탈착이 용이한 스틱 걸이
MX2019002149A (es) * 2016-08-23 2019-09-18 Neurim Pharma 1991 Metodo para el tratamiento de prurito y/o comezon.
EP3577103A1 (en) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
CN108324724A (zh) * 2018-04-10 2018-07-27 苏州芝宇生物科技有限公司 一种克立硼罗可溶性膜制剂的制法及其应用
CN113423394A (zh) 2019-02-14 2021-09-21 久光制药株式会社 泥罨剂

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
JPS62169723A (ja) * 1986-01-22 1987-07-25 Teisan Seiyaku Kk 徐放化製剤
JPS63238024A (ja) * 1987-03-26 1988-10-04 Towa Yakuhin Kk 水難溶性薬物を含有する外用ゲル組成物
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH01294620A (ja) * 1988-05-19 1989-11-28 Kissei Pharmaceut Co Ltd 水溶液製剤およびその製造方法
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
JPH0794378B2 (ja) * 1989-08-18 1995-10-11 久光製薬株式会社 エアゾール剤
JP3243564B2 (ja) * 1990-08-20 2002-01-07 リードケミカル株式会社 外用貼付剤
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
JPH05163222A (ja) * 1991-12-18 1993-06-29 Kissei Pharmaceut Co Ltd コラーゲン過剰合成疾患治療剤
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
JPH06128153A (ja) * 1992-10-16 1994-05-10 Kissei Pharmaceut Co Ltd トラニラスト軟膏組成物およびその製造方法
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5725874A (en) * 1993-05-19 1998-03-10 Hisamitsu Pharmaceutical Co., Inc. Solubilizer and external preparations containing the same
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
FR2736048B1 (fr) * 1995-06-27 1997-08-01 Atochem Elf Sa Synthese du difluoromethane
CA2208332A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. Drug administration composition for iontophoresis

Also Published As

Publication number Publication date
JP4154621B2 (ja) 2008-09-24
DE69715049D1 (de) 2002-10-02
DE974350T1 (de) 2001-01-25
EP0974350A1 (en) 2000-01-26
WO1997028793A1 (fr) 1997-08-14
ES2151464T1 (es) 2001-01-01
PT974350E (pt) 2002-12-31
KR100449939B1 (ko) 2004-11-20
HK1018218A1 (en) 1999-12-17
EP0974350B1 (en) 2002-08-28
CN1081030C (zh) 2002-03-20
KR19990082254A (ko) 1999-11-25
EP0974350A4 (en) 2000-01-26
ATE222759T1 (de) 2002-09-15
CN1210462A (zh) 1999-03-10
DE69715049T2 (de) 2003-04-03
US6239177B1 (en) 2001-05-29
ES2151464T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
DK0974350T3 (da) Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette
DE60045153D1 (de) Zubereitungen zur perkutanen absorption
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
BRPI0412975A (pt) espuma penetrante para uso farmacêutico
FI962770A0 (fi) Transdermaalinen laite, joka sisältää polyvinyylipyrrolidonia liukoisuutta parantavana aineena
DK1299108T3 (da) Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat
PT922453E (pt) Preparacao do tipo de absorcao percutanea contendo tulobuterol
ES2085886T3 (es) Composicion farmaceutica de liberacion contenida.
NO945103L (no) Ribozym med en termodynamisk stabil lökke
DE59703711D1 (de) Ophtalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
HK1084588A1 (en) Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
DK0697814T3 (da) Hæld-på-formuleringer indeholdende polymert materiale glycoler og glycerider
DE69720269D1 (de) Gelierungsstabiele polyhalogenphosphazenverbindungen
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
GR1001511B (el) Στεροειδείς συν?έσεις.
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
DK0818973T3 (da) Bionedbrydelig indretning
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE69828586D1 (de) Azelastinhydrochlorid enthaltende zubereitung mit guter perkutaner absorptionsfähigkeit und verringerter hautreizbarkeit
ATE258446T1 (de) Benzophenanthridinalkaloid-enthaltende pestizide
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
HK1009400A1 (en) Combination drug containing tramadol and a calcium channel antagonist
RU97111095A (ru) Препарат для профилактики и лечения гельминтозов животных "альбамелин"
BR0014058A (pt) Produto sólido, composição, solução aquosa de 4,4-dimetil-5a-colesta-8,14,24-triene-3(beta) -ol, e, dispositivo tendo uma concavidade